Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: The Munich General Practitioner Project

Diabetologia

Volumn 39, Issue 12, 1996, Pages 1540-1545

  Standl, E ^a   Balletshofer, B ^a   Dahl, B ^a   Weichenhain, B ^a   Stiegler, H ^a   Hormann A ^b   Holle, R ^b  

^a Klinikum Schwabing   (Germany)

^b Institute for Medical Informatics   (Germany)

Author keywords

blood pressure; HbA(1c); lipids; macrovascular mortality; mortality; non insulin dependent diabetes mellitus; urine albumin excretion; von Willebrand factor

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; ENDOTHELIUM INJURY; FEMALE; FOLLOW UP; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; VON WILLEBRAND FACTOR;

EID: 0029857628     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050612     Document Type: Conference Paper

References (37)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444
2. Panzram G (1987) Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 123-131
3. Laakso M, Rönnemaa T, Pyörälä K, Kallio P, Punka P, Penttila I (1988) Atherosclerotic vascular disease and its risk factors in non-insulin-dependent and non-diabetic subjects in Finland. Diabetes Care 11: 449-463
4. Hanefeld M, Fischer S, Schmechel H (1991) Diabetes Intervention Study: multiple intervention trial in newly diagnosed NIDDM. Diabetes Care 14: 308-317
5. 1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41: 202-208
6. Thoelke H, Meusel K (1994) Zur Überlebensdauer von Typ-II-Diabetikern. Ergebnisse einer 20-jährigen Follow-up-Studie in Berlin Ost. Diskussionsbeiträge zur Gesundheitsforschung, Senatsverwaltung für Gesundheit, Berlin, Papier 19, pp 1-33
7. Standl E (1995) Hyperinsulinemia and atherosclerosis. J Clin Invest Med 18: 261-266
8. Janka HU, Balletshofer B, Becker A, Gick NR, Hartmann J, Möckelmann S, Möltner A (1992) The metabolic syndrome as a potent risk factor for premature death in NIDDM: The Schwabing Study - 9 year follow up. Diab Stoffw 1: 2-7
9. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W (1993) Frequency, risk profile and mortality of a random sample of albuminurie type 2 diabetic patients. A 5 year prospective study in general practice. Diab Stoffw 2: 62-67
10. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and nondiabetic sujects. Diabetologia 36: 1175-1184
11. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356-360
12. Jarrett TJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells RJ (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med 1: 17-19
13. Schmitz A, Vaeth M (1988) Microalbuminuria: a major risk factor in non-insulin dependent diabetes: a 10 year follow-up of 503 patients. Diabet Med 5: 126-134
14. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G (1992) Prospective study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes 41: 736-741
15. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J (1993) A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16: 994-1003
16. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W (1992) Morbidity, mortality and albuminuria in type 2 diabetic patients: a three-year prospective study of a random cohort in general practice. Diabet Med 9: 646-653
17. McLeod JM, Lutale J, Marshall SM (1995) Albumin excretion and vascular deaths in NIDDM. Diabetologia 38: 610-616
18. The Diabetes Control and Complications Trail Research Group (1993) The effect of intensive treatment of diabetes on the development of long term complications in insulin dependent diabetes mellitus. N Engl J Med 329: 977-986
19. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M (1994) NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43: 960-967
20. Uusitupa MIJ, Niskanen LK (1995) Hyperglycemia and cardiovascular risk in NIDDM. Diabetes Care 18: 884-885
21. Selby JV, Zhang D (1995) Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care 18: 509-516
22. Ingerslev J (1995) Research methodologies in measurement of platelet function, endothelial proteins, coagulation factors and fibrinolysis. In: Mogensen CE, Standl E (eds) Research methodologies in human diabetes. Part 2. De Gruyter, Berlin New York pp 125-146
23. Standl R, Stiegler H, Rebell B et al. (1990) Der Typ-II-Diabetes in der Praxis des niedergelassenen Arztes, Konzept einer zentrumsgestützten Betreuung und Ergebnisse einer Stichprobenerhebung im Großraum München. Akt Endokr Stoffw 11: 222-227
24. Standl E, Stiegler H (1993) Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich Area. Diabetologia 36: 1017-1020
25. Michaelis D, Jutzi E (1991) Epidemiologie des Diabetes mellitus in der Bevölkerung der ehemaligen DDR. Alters-und geschlechtsspezifische Inzidenz- und Prävalenztrends im Zeitraum 1960-1987. Z Klin Med 46: 59-66
26. WHO Study Group (1985) Diabetes mellitus. Technical report series 727. WHO, Geneva pp 1-113
27. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary heart disease risk and impaired glucose tolerance: the Whitehall study. Lancet I: 1373-1376
28. Köhler M, Roth FJ, El-Mamoun B (1982) Untersuchungen über die Spezifität der peripheren systolischen Druckmessung mit der Ultraschall-Doppler-Technik an gesunden angiographierten Extremitäten. Z Kardiol 71: 156-162
29. Kriessmann A, Bollinger A, Keller H [eds] (1982) Praxis der Doppler-Sonographie. Thieme, Stuttgart pp 1-51
30. Zimmermann TS, Hoyer LW, Dickson L, Edington TS (1975) Determination of the von Willebrand's disease antigen (factor VIII related antigen) in plasma by quantitative immune electrophoresis. J Lab Clin Med 86: 152-159
31. Bergmeyer HU [ed] (1985) Methods of enzymatic analysis. 3rd edn. VCH Verlagsgemeinschaft, Weinheim
32. Morris MJ (1986) SPSS/PC+: SPSS for the IBM PC/XT/ AT. SPSS inc., Chicago
33. Cox DR (1970) The analysis of binary data. Methuen, London
34. UKPDS Study Group: Holman RR, Cull CA, Fox D, Turner RC (1995) UKPDS 13: Relative efficacy of randomly allocated diet, sulfonylurea, insulin or metformin in patients with newly diagnosed type 2 diabetes followed for three years. BMJ 310: 83-88
35. Janka HU, Standl E, Schramm W, Mehnert H (1983) Platelet enzyme activities in diabetes mellitus in relation to endothelial damage. Diabetes 32 [Suppl 2]: 47-51
36. Stehouwer CDA, Nanta JJP, Zeldenrust GC (1992) Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin dependent diabetes mellitus. Lancet 340: 319-323
37. Kannel WB, McGee DL (1979) Diabetes and cardiovascular risk factors in the Framingham Study. Circulation 59: 8-13